Correction: Ring finger protein 180 suppresses cell proliferation and energy metabolism of non-small cell lung cancer through downregulating C-myc

Correction: World J Surg Oncol 20, 162 (2022)

https://doi.org/10.1186/s12957-022-02599-x

Following the publication of the original article, the author reported an error in Fig. 1E. The correct figure is included in this correction and the original article has been updated.

Fig. 1.

RNF180 was downregulated in non-small cell lung cancer (NSCLC) and positively correlated with its overall survival rate. A RNF180 expression in patients with lung adenocarcinoma (LUAD) (n = 526) and healthy individuals (n = 59) was analyzed based on the TCGA database. *** p<0.001 vs para-cancerous. B Survival probability of patients with LUAD exhibiting high RNF180 expression (n = 120) and low-to-medium RNF180 expression (n = 119) was analyzed using the Kaplan–Meier method. C RNF180 mRNA levels in 30 pairs of tumorous and adjacent normal tissues were measured using qRT-PCR. *** p<0.001 vs para-cancerous. D Representative IHC image of RNF180 expression in tissues of healthy controls (n = 5) and patients with NSCLC (n = 93) was assessed using the IHC assay (original magnification 200×). Representative IHC image is presented. E Overall survival probability of patients with NSCLC was analyzed using the Kaplan–Meier method and compared between high RNF180-expressed (n = 53) and low RNF180-expressed (n = 40) groups